Historical salary details - Dr. Samarth Kulkarni, PhD, Independent Director, Centessa Pharmaceuticals plc - ADR
Dr. Samarth Kulkarni, PhD is the Independent Director of Centessa Pharmaceuticals plc - ADR. They also hold 4 other positions in Black Diamond Therapeutics Inc, Repare Therapeutics Inc, Oruka Therapeutics Inc. and CRISPR Therapeutics AG.
Dr. Samarth Kulkarni, Phd
Independent Director
$ 657.3 K
Gross Remuneration
-
Current Company
Centessa Pharmaceuticals plc - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Centessa Pharmaceuticals plc - ADR | Independent Director | 339.7 K | 33.1 % |
| 2024 | Black Diamond Therapeutics Inc | Lead Independent Director | 171.3 K | 188.7 % |
| 2024 | Repare Therapeutics Inc | Independent Director | 118.4 K | -55.4 % |
| 2024 | Oruka Therapeutics Inc. | Chairman of the Board | 27.7 K | - |
| 2024 | CRISPR Therapeutics AG | Chairman of the Board and Chief Executive Officer | - | - |
| 2023 | Repare Therapeutics Inc | Independent Director | 265.3 K | -19.4 % |
| 2023 | Centessa Pharmaceuticals plc - ADR | Independent Director | 255.2 K | - |
| 2023 | Black Diamond Therapeutics Inc | Independent Director | 59.3 K | -2.4 % |
| 2023 | Oruka Therapeutics Inc. | Chairman of the Board | - | - |
| 2023 | CRISPR Therapeutics AG | Chairman of the Board and Chief Executive Officer | - | - |
| 2022 | Repare Therapeutics Inc | Independent Director | 329.2 K | -29.1 % |
| 2022 | Black Diamond Therapeutics Inc | Independent Director | 60.8 K | -84.1 % |
| 2022 | CRISPR Therapeutics AG | Chief Executive Officer and Director | - | - |
| 2022 | Centessa Pharmaceuticals plc - ADR | Independent Director | - | - |
| 2021 | Centessa Pharmaceuticals plc - ADR | Independent Director | 800.8 K | - |
| 2021 | Repare Therapeutics Inc | Independent Director | 464.0 K | 958.5 % |
| 2021 | Black Diamond Therapeutics Inc | Independent Director | 382.5 K | 856.3 % |
| 2021 | CRISPR Therapeutics AG | Chief Executive Officer and Director | - | - |
| 2020 | Repare Therapeutics Inc | Independent Director | 43.8 K | -63.3 % |
| 2020 | Black Diamond Therapeutics Inc | Independent Director | 40 K | -88.3 % |
| 2020 | Centessa Pharmaceuticals plc - ADR | Independent Director | - | - |
| 2020 | CRISPR Therapeutics AG | Chief Executive Officer and Director | - | - |
| 2019 | Black Diamond Therapeutics Inc | Independent Director | 342.9 K | - |
| 2019 | Repare Therapeutics Inc | Director | 119.3 K | - |
| 2019 | CRISPR Therapeutics AG | Chief Executive Officer and Director | - | - |
| 2018 | CRISPR Therapeutics AG | Chief Executive Officer and Director | - | - |